View Filing Data

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Nov. 04, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	AMN HEALTHCARE SERVICES INC
Entity Central Index Key	0001142750
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		47,693,968

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 14,408	$ 13,073
Accounts receivable, net of allowances of $7,460 and $4,515 at September 30, 2015 and December 31, 2014, respectively	248,779	186,274
Accounts receivable, subcontractor	49,521	28,443
Deferred income taxes, net	18,378	27,330
Prepaid expenses	12,818	10,350
Other current assets	25,077	17,200
Total current assets	368,981	282,670
Restricted cash, cash equivalents and investments	25,425	19,567
Fixed assets, net of accumulated depreciation of $74,460 and $68,814 at September 30, 2015 and December 31, 2014, respectively	45,407	32,880
Other assets	46,634	39,895
Goodwill	201,444	154,387
Intangible assets, net of accumulated amortization of $50,725 and $41,963 at September 30, 2015 and December 31, 2014, respectively	177,347	152,517
Total assets	865,238	681,916
Current liabilities:
Accounts payable and accrued expenses	113,152	78,993
Accrued compensation and benefits	88,492	67,995
Current portion of revolving credit facility	30,000	18,000
Current portion of notes payable	7,500	7,500
Deferred revenue	4,944	3,177
Other current liabilities	6,026	2,630
Total current liabilities	250,114	178,295
Revolving credit facility	45,500	0
Notes payable	131,250	136,875
Deferred income taxes, net	39,000	32,491
Other long-term liabilities	75,409	77,674
Total liabilities	541,273	425,335
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September 30, 2015 and December 31, 2014	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 47,694 and 46,639 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	477	466
Additional paid-in capital	440,465	434,529
Accumulated deficit	(116,332)	(178,058)
Accumulated other comprehensive loss	(645)	(356)
Total stockholders’ equity	323,965	256,581
Total liabilities and stockholders’ equity	$ 865,238	$ 681,916

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 7,460	$ 4,515
Accumulated depreciation	74,460	68,814
Accumulated amortization	$ 50,725	$ 41,963
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	47,694,000	46,639,000
Common stock, shares outstanding	47,694,000	46,639,000

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Revenue	$ 382,859	$ 264,584	$ 1,060,513	$ 756,378
Cost of revenue	256,850	184,278	722,954	524,957
Gross profit	126,009	80,306	337,559	231,421
Operating expenses:
Selling, general and administrative	83,098	60,319	229,377	170,553
Depreciation and amortization	5,304	4,086	15,631	11,916
Total operating expenses	88,402	64,405	245,008	182,469
Income from operations	37,607	15,901	92,551	48,952
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013	1,433	5,797	7,908
Income before income taxes	35,594	14,468	86,754	41,044
Income tax expense	1,947	5,969	25,028	17,722
Net income	33,647	8,499	61,726	23,322
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Foreign currency translation	54	75	42	29
Unrealized loss on cash flow hedge, net of income taxes	(367)	0	(331)	0
Other comprehensive income (loss):	(313)	75	(289)	29
Comprehensive income	$ 33,334	$ 8,574	$ 61,437	$ 23,351
Net income per common share:
Basic (in dollars per share)	$ 0.71	$ 0.18	$ 1.30	$ 0.50
Diluted (in dollars per share)	$ 0.69	$ 0.18	$ 1.27	$ 0.49
Weighted average common shares outstanding:
Basic (shares)	47,674	46,546	47,466	46,460
Diluted (shares)	48,978	48,122	48,737	47,959

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Loss on debt extinguishment	$ 0	$ 0	$ 3,113

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 61,726	$ 23,322
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions:
Depreciation and amortization	15,631	11,916
Non-cash interest expense and other	1,445	1,104
Loss on debt extinguishment	0	3,113
Change in fair value of contingent consideration	(300)	0
Increase in allowances for doubtful accounts and sales credits	5,315	2,915
Provision for deferred income taxes	17,683	1,768
Share-based compensation	6,551	5,361
Excess tax benefits from share-based compensation	(7,269)	(1,780)
Loss on disposal or sale of fixed assets	3	50
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(46,732)	(19,516)
Accounts receivable, subcontractor	(21,078)	(3,298)
Income taxes receivable	1,008	484
Prepaid expenses	(2,213)	(1,935)
Other current assets	(6,111)	(733)
Other assets	(3,454)	(188)
Accounts payable and accrued expenses	25,808	(4,302)
Accrued compensation and benefits	16,707	8,625
Other liabilities	(4,365)	4,662
Deferred revenue	1,140	(37)
Restricted cash, cash equivalents and investments balance	(5,858)	(9,038)
Net cash provided by operating activities	55,637	22,493
Cash flows from investing activities:
Purchase and development of fixed assets	(21,122)	(14,287)
Equity method investment in Pipeline Health Holdings LLC	(1,000)	(5,000)
Payments to fund deferred compensation plan	(2,250)	(2,174)
Cash paid for acquisitions, net of cash received	(81,097)	0
Cash paid for working capital adjustments for prior year acquisition	(165)	0
Change in restricted cash, cash equivalents and investments balance	0	11,141
Net cash used in investing activities	(105,634)	(10,320)
Cash flows from financing activities:
Capital lease repayments	(4)	(472)
Payments on term loan	(5,625)	(153,370)
Proceeds from term loan	0	150,000
Payments on revolving credit facility	(27,000)	(39,500)
Proceeds from revolving credit facility	84,500	29,500
Payment of financing costs	0	(3,488)
Proceeds from exercise of equity awards	3,663	1,792
Cash paid for shares withheld for taxes	(11,513)	(4,361)
Excess tax benefits from share-based compensation	7,269	1,780
Net cash provided by (used in) financing activities	51,290	(18,119)
Effect of exchange rate changes on cash	42	29
Net increase (decrease) in cash and cash equivalents	1,335	(5,917)
Cash and cash equivalents at beginning of period	13,073	15,580
Cash and cash equivalents at end of period	14,408	9,663
Supplemental disclosures of cash flow information:
Cash paid for interest (net of $173 and $83 capitalized for the nine months ended September 30, 2015 and 2014, respectively)	4,334	3,687
Cash paid for income taxes	20,655	12,732
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash received	26,340	0
Goodwill	46,891	0
Intangible assets	33,592	0
Liabilities assumed	(22,526)	0
Holdback provision	(500)	0
Earn-out liabilities	(2,700)	0
Net cash paid for acquisitions	(81,097)	0
Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses	2,206	3,751
Convertible loan converted to equity method investment in Pipeline Health Holdings LLC	$ 1,000	$ 0

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Statement of Cash Flows [Abstract]
Interest capitalized	$ 173	$ 83

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period. The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2014, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the Securities and Exchange Commission on February 25, 2015 (“2014 Annual Report”). The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. Reclassification Certain reclassifications that are not material have been made to the prior year’s consolidated financial statements to conform to the current year presentation.

Business Combinations

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

BUSINESS COMBINATIONS

The First String Healthcare Acquisition

On September 15, 2015, the Company completed its acquisition of The First String Healthcare (“TFS”), a leading provider of interim staffing and permanent placement of nurse leaders and executives. The total purchase price of $7,653 included (1) $4,453 cash consideration paid upon acquisition, funded by cash-on-hand, net of cash received, (2) $500 to be paid on the first anniversary of the acquisition date, and (3) a contingent earn-out with a fair value of $2,700 as of the acquisition date. Also, the purchase agreement included an additional $1,000 payment to be paid on the second anniversary of the acquisition date conditioned upon, subject to certain exceptions, continued employment of the selling shareholders, which will be recorded as compensation expense for post-combination services. The acquisition is intended to enhance the Company’s capabilities to provide interim and permanent nursing leadership. As the acquisition is not considered significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $4,000, of which (1) up to $1,000 may be paid to the sellers in 2016 based on the operating results of TFS for the 12-month period ending December 31, 2015 and (2) up to $3,000 may be paid in 2017 based on the operating results of TFS for the 12-month period ending December 31, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $920 of fair value of tangible assets acquired, $867 of liabilities assumed, $3,373 of identified intangible assets and $4,228 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships staffing database and covenant not to compete. The weighted average useful life of the acquired intangible assets subject to amortization is approximately seven years.

The results of operations of TFS are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements since the date of acquisition.

Onward Healthcare Acquisition

On January 7, 2015, the Company completed its acquisition of Onward Healthcare, including its two wholly-owned subsidiaries, Locum Leaders and Medefis (collectively, “OH”), for approximately $76,643 in cash, funded by cash-on-hand and borrowings under the Company’s revolving credit facility. Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a provider of a software as a service, or “SaaS,” based vendor management system for healthcare facilities. The acquisition helps the Company to expand its service lines and its supply and placement capabilities of healthcare professionals to its clients.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the $76,643 purchase price consisted of $25,420 of fair value of tangible assets acquired (including $20,269 of accounts receivable), $21,659 of liabilities assumed (including $10,534 of accounts payable and accrued expenses), $30,219 of identified intangible assets, and $42,663 of goodwill, a portion of which is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships, staffing database, acquired technologies and non-compete agreements. The weighted average useful life of the acquired intangible assets is approximately 11 years. The following table summarizes the fair value and useful life of each intangible asset acquired:



		Fair Value		Useful Life
				(in years)
Identifiable intangible assets
	Tradenames and Trademarks	$	8,100	3 - 15
	Customer Relationships	17,600		10 - 15
	Staffing Database	2,600		5
	Acquired Technologies	1,700		8
	Non-compete agreements	219		2
		$	30,219

Of the $42,663 allocated to goodwill, $37,422 and $5,241 were allocated to the Company’s nurse and allied healthcare staffing segment and locum tenens staffing segment, respectively.

The results of Onward Healthcare and Medefis are included in the Company’s nurse and allied healthcare staffing segment and the results of Locum Leaders are included in the Company’s locum tenens staffing segment since the date of acquisition. For the three months ended September 30, 2015, approximately $39,145 of revenue and $4,774 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations. For the nine months ended September 30, 2015, approximately $106,492 of revenue and $11,416 of income before income taxes of the OH entities were included in the unaudited condensed consolidated statement of operations.

The following summary presents unaudited pro forma consolidated results of operations of the Company for the three and nine months ended September 30, 2015 and 2014 as if the OH acquisition described above had occurred on January 1, 2014. The following unaudited pro forma financial information gives effect to certain adjustments, including the reduction in compensation expense related to non-recurring executive salary expense, acquisition-related costs and the amortization of acquired intangible assets. The pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor are they necessarily indicative of future operating results.



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue	$	382,859	$	293,072	$	1,062,798	$	838,109
Net income	$	34,350	$	9,091	$	63,513	$	24,088
Net income per common share:
Basic	$	0.72	$	0.20	$	1.34	$	0.52
Diluted	$	0.70	$	0.19	$	1.30	$	0.50

Avantas Acquisition

On December 22, 2014, the Company completed its acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology, for $17,520, which the Company funded through cash-on-hand and borrowings under its revolving credit facility. The total purchase price of $17,520 included $14,470 cash consideration paid, $1,650 cash holdback for potential working capital claims, and contingent earn-out payments with a fair value of $1,400 as of the acquisition date. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015. During the nine months ended September 30, 2015, the Company paid an additional $165 to the selling equityholders for a working capital adjustment. The acquisition is intended to help enable the Company to provide a level of workforce predictability to clients that can be integrated with its workforce and staffing solutions. As the acquisition is not significant, pro forma information is not provided. The Company did not incur any material acquisition-related costs.

The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The acquisition agreement provides for a tiered contingent earn-out payment of up to $8,500 to be paid in 2016 based on the operating results of Avantas for the 12-month period ending June 30, 2016. As of the filing date of this Form 10-Q, the Company is still finalizing the allocation of the purchase price, primarily related to tax matters.

The preliminary allocation of the purchase price consisted of $1,631 of fair value of tangible assets acquired, $3,821 of liabilities and deferred revenue assumed, $9,960 of identified intangible assets and $9,916 of goodwill, which goodwill is deductible for tax purposes. The intangible assets include the fair value of tradenames and trademarks, customer relationships and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 14 years.

The results of operations of Avantas are included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Revenue Recognition	9 Months Ended
Revenue Recognition	Sep. 30, 2015
Revenue Recognition [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $53,575 and $33,474 were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of September 30, 2015 and the audited consolidated balance sheet as of December 31, 2014, respectively.

Net Income Per Common Share

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

NET INCOME PER COMMON SHARE

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.

Share-based awards to purchase 286 shares of common stock were not included in the calculation of diluted net income per common share for the three months ended September 30, 2014 because the effect of these instruments was anti-dilutive. Share-based awards to purchase 12 and 344 shares of common stock were not included in the calculation of diluted net income per common share for the nine months ended September 30, 2015 and 2014, respectively, because the effect of these instruments was anti-dilutive.

The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2015 and 2014, respectively:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Net income	$	33,647	$	8,499	$	61,726	$	23,322

Net income per common share - basic	$	0.71	$	0.18	$	1.30	$	0.50
Net income per common share - diluted	$	0.69	$	0.18	$	1.27	$	0.49

Weighted average common shares outstanding - basic	47,674		46,546		47,466		46,460
Plus dilutive effect of potential common shares	1,304		1,576		1,271		1,499
Weighted average common shares outstanding - diluted	48,978		48,122		48,737		47,959

Segment Information

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

SEGMENT INFORMATION

The Company has three reportable segments: (1) nurse and allied healthcare staffing, (2) locum tenens staffing, and (3) physician permanent placement services.

The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.

The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue
Nurse and allied healthcare staffing	$	266,279	$	174,292	$	735,341	$	503,636
Locum tenens staffing	101,755		78,816		285,835		219,996
Physician permanent placement services	14,825		11,476		39,337		32,746
	$	382,859	$	264,584	$	1,060,513	$	756,378
Segment Operating Income
Nurse and allied healthcare staffing	$	40,873	$	21,279	$	108,169	$	63,283
Locum tenens staffing	13,321		8,139		34,142		22,830
Physician permanent placement services	4,555		2,756		11,103		7,074
	58,749		32,174		153,414		93,187
Unallocated corporate overhead	13,817		10,396		38,681		26,958
Depreciation and amortization	5,304		4,086		15,631		11,916
Share-based compensation	2,021		1,791		6,551		5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013		1,433		5,797		7,908
Income before income taxes	$	35,594	$	14,468	$	86,754	$	41,044

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Derivative Instruments	9 Months Ended
Derivative Instruments	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS In April 2015, the Company entered into an interest rate swap agreement to minimize its exposure to interest rate fluctuations on $100,000 of its outstanding variable rate debt under its existing term loan facility whereby the Company pays a fixed rate of 0.983% per annum and receives a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into this agreement. At September 30, 2015, the interest rate swap agreement had a fair value of $(542), which is included in other long-term liabilities in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2015. The Company has formally documented the hedging relationship and accounts for this arrangement as a cash flow hedge. The Company recognizes all derivatives on the balance sheet at fair value based on quotes from an independent pricing service. Gains or losses resulting from changes in the values of the arrangement are recorded in other comprehensive income (loss), net of tax, until the hedged item is recognized in earnings. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivative instrument that is used in the hedging transaction is highly effective in offsetting changes in fair values or cash flows of the hedged item. When it is determined that a derivative instrument is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively and recognizes subsequent changes in market value in earnings.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Fair Value Measurement

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT

The Company’s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2 and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 4 - Fair Value Measurement” of the 2014 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2015, except for the new interest rate swap agreement entered into in April 2015.

Assets and Liabilities Measured on a Recurring Basis

The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit.

The Company’s interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap has been measured as of September 30, 2015 in accordance with Level 2 input of the fair value hierarchy using an independent pricing service, which the Company believes is an industry standard model that considers time value, current market and contractual prices for the underlying instrument, volatility factors and other relevant economic measures. The valuation also consider credit risk adjustments that are necessary to reflect the probability of default by the counterparty or the Company, which are considered Level 3 inputs; however, as of September 30, 2015, the credit risk adjustments, including nonperformance risk, were considered insignificant to the total fair value of the interest rate swaps.

The Company has an obligation to pay earn-out consideration of up to $8,500 to the selling equity holders if Avantas meets certain future financial metrics for the 12-month period ending June 30, 2016. The Company also has an obligation to pay earn-out consideration of up to $4,000 to the selling shareholders if TFS meets certain future financial metrics for calendar years 2015 and 2016. The earn-out liabilities in connection with both acquisitions were estimated based on estimated cash flows determined using the probability-weighted average of possible outcomes that would occur should certain financial metrics be reached. As there is no market data available to use in valuing the contingent consideration, the Company developed its own assumptions related to the future financial performance of Avantas and TFS to estimate the fair value of the liabilities. As such, the contingent consideration liabilities are classified within Level 3.

In connection with estimating the fair value of the contingent consideration for Avantas, the Company estimates the weighted probability of Avantas earning each of the five specified tiered earn-out amounts of $0, $1,500, $3,500, $5,500 and $8,500, which are each tied to the financial performance of Avantas for the 12-month period ending June 30, 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value. As of September 30, 2015, the fair value of the contingent consideration liability was remeasured at $1,100, which resulted in a decrease in operating expenses of $300 during the three and nine months ended September 30, 2015.

In connection with estimating the fair value of the contingent consideration for TFS, the Company estimates the weighted probability of TFS earning each of the three specified tiered earn-out amounts of $0, $500, and $1,000, which are each tied to the financial performance of TFS for calendar year 2015 and each of the six specified tiered earn-out amounts of $0, $1,000, $1,500, $2,000, $2,500 and $3,000, which are each tied to the financial performance of TFS for calendar year 2016. An increase or decrease in the probability of achievement will result in an increase or decrease to the estimated fair value of the contingent consideration. The Company reassesses the fair value each reporting period and adjusts the liability to its then fair value.

The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:



	Fair Value Measurements as of September 30, 2015
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds	$	5,626	$	5,626	$	—	$	—
Interest rate swap liability	542		—		542		—
Acquisition contingent consideration earn-out liabilities	3,800		—		—		3,800
Total financial assets and liabilities measured at fair value	$	9,968	$	5,626	$	542	$	3,800



	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets and liabilities measured at fair value	$	7,026	$	5,626	$	—	$	1,400

Level 3 Information

The following table sets forth reconciliations of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:



	Three months ended September 30,
	2015			2014
Balance as of July 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—



	Nine months ended September 30,
	2015			2014
Balance as of January 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

Assets Measured on a Non-Recurring Basis

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment.

The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.

There were no triggering events identified and no indication of impairment of the Company’s goodwill, indefinite-lived intangible assets, long-lived assets or equity method investment during the nine months ended September 30, 2015 and 2014.

Fair Value of Financial Instruments

The carrying amount of the Company’s notes payable and revolving credit facility approximate their fair value as the instruments’ interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity. The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company is subject to income taxation in the U.S. and various states and foreign jurisdictions. As of September 30, 2015, the Company is no longer subject to U.S. federal income or payroll tax examinations before 2011. With few exceptions, as of September 30, 2015, the Company is no longer subject to state, local or foreign income tax examinations by tax authorities for tax years before 2006. The Company’s tax years 2007, 2008, 2009 and 2010 had been under audit by the Internal Revenue Service (“IRS”) for several years and, in 2014, the IRS issued the Company its Revenue Agent Report (“RAR”) and an Employment Tax Examination Report (“ETER”). The RAR proposed adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006, resulting from the proposed disallowance of certain per diems paid to the Company’s healthcare professionals, and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2009 and 2010 related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER were mutually exclusive, and contain multiple tax positions, some of which were contrary to each other. The Company filed a Protest Letter for both the RAR and ETER positions in 2014. The Company received a final determination from the IRS in July 2015 on both the RAR adjustments and ETER assessments and the federal audit was settled for $7,200 (including interest) during the third quarter of 2015. As a result, the Company recorded federal income tax benefits of approximately $12,200 during the quarter ended September 30, 2015 and expects to record the state income tax benefits of approximately $1,500 by the quarter ending December 31, 2016, when the various state statutes are projected to lapse. The IRS had also been conducting a separate audit of the Company’s 2011 and 2012 tax years. The income and employment tax issues addressed in the 2011 and 2012 examination are consistent with the issues raised in the 2007 through 2010 examination. During the quarter ended March 31, 2015, the IRS completed its 2011 and 2012 examination and issued its RAR and ETER to the Company. The proposed adjustments to the Company’s taxable income for 2011 and 2012 and net operating loss carryforwards from 2010 and the ETER proposed assessments for additional payroll tax liabilities and penalties for 2011 and 2012 are related to the Company’s treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER for the 2011 and 2012 years are mutually exclusive and contain multiple tax positions, some of which are contrary to each other. The Company has filed a Protest Letter for both the RAR and ETER in April 2015. The Company intends to defend its position. The IRS began an audit of the Company’s 2013 tax year during the quarter ended June 30, 2015. The Company believes its reserves are adequate with respect to these open years.

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES (a) Legal From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. Additionally, some of its clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s healthcare professionals. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. With regards to outstanding loss contingencies as of September 30, 2015, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations or cash flows. (b) Leases On January 26, 2015, the Company entered into a 10-year operating lease agreement for office space in Dallas, Texas that replaced its current operating lease agreement for its Irving, Texas offices, which expired in August 2015. Base rent payments under the new lease agreement began in September 2015 and the total estimated base rent payments will be approximately $23,956 over the life of the lease, which is ten years. The rent payments have been included in the total minimum lease payment table set forth in Part II, Item 8, “Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 12(b) - Commitments and Contingencies - Leases” of the Company’s 2014 Annual Report.

Balance Sheet Details

9 Months Ended

Sep. 30, 2015

Balance Sheet Related Disclosures [Abstract]

BALANCE SHEET DETAILS

The consolidated balance sheets detail is as follows as of September 30, 2015 and December 31, 2014:



	September 30, 2015			December 31, 2014
Other current assets:
Restricted cash	$	13,143		$	9,054
Income taxes receivable	4,195			3,503
Other	7,739			4,643
Other current assets	$	25,077		$	17,200

Fixed assets:
Furniture and equipment	$	21,158		$	17,761
Software	93,485			78,593
Leasehold improvements	5,224			5,340
	119,867			101,694
Accumulated depreciation and amortization	(74,460		)	(68,814		)
Fixed assets, net	$	45,407		$	32,880

Accounts payable and accrued expenses:
Trade accounts payable	$	48,109		$	30,039
Subcontractor payable	53,575			33,474
Professional liability reserve	7,403			7,380
Overdraft	2,548			6,338
Other	1,517			1,762
Accounts payable and accrued expenses	$	113,152		$	78,993

Accrued compensation and benefits:
Accrued payroll	$	32,569		$	21,857
Accrued bonuses	20,218			15,196
Accrued travel expense	2,868			2,413
Accrued health insurance reserve	2,517			1,871
Accrued workers compensation reserve	7,539			5,830
Deferred compensation	21,968			20,729
Other	813			99
Accrued compensation and benefits	$	88,492		$	67,995

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On October 5, 2015, the Company completed its acquisition of Millican Solutions, Inc., a physician and executive leadership search firm serving academic medical centers nationwide for $4,075 in cash. The acquisition is intended to enhance the Company’s ability to respond to the specialized leadership needs within academic pediatrics and children’s medical centers and expands the Company’s expertise in serving academic medical centers and teaching hospitals in physician and leadership search.

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Revenue Recognition	Revenue consists of fees earned from the permanent and temporary placement of healthcare professionals. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its healthcare professionals along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client.
Net Income per Common Share	Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments.
Segment Information	The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense (net) and other, and unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
Derivative Instruments	The Company recognizes all derivatives on the balance sheet at fair value based on quotes from an independent pricing service. Gains or losses resulting from changes in the values of the arrangement are recorded in other comprehensive income (loss), net of tax, until the hedged item is recognized in earnings. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivative instrument that is used in the hedging transaction is highly effective in offsetting changes in fair values or cash flows of the hedged item. When it is determined that a derivative instrument is not highly effective as a hedge or that it has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively and recognizes subsequent changes in market value in earnings.
Fair Value of Financial Instruments	Assets Measured on a Non-Recurring Basis The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets and equity method investment. The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs. Assets and Liabilities Measured on a Recurring Basis The Company’s assets that are measured at fair value on a recurring basis include restricted cash equivalents and investments. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit. The Company’s interest rate swap is required to be measured at fair value on a recurring basis. The fair value of the interest rate swap has been measured as of September 30, 2015 in accordance with Level 2 input of the fair value hierarchy using an independent pricing service, which the Company believes is an industry standard model that considers time value, current market and contractual prices for the underlying instrument, volatility factors and other relevant economic measures. Fair Value of Financial Instruments The carrying amount of the Company’s notes payable and revolving credit facility approximate their fair value as the instruments’ interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity. The fair value of the Company’s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References + Details

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Summary of Fair Value and Useful Life of Each Intangible Asset Acquired

The following table summarizes the fair value and useful life of each intangible asset acquired:



		Fair Value		Useful Life
				(in years)
Identifiable intangible assets
	Tradenames and Trademarks	$	8,100	3 - 15
	Customer Relationships	17,600		10 - 15
	Staffing Database	2,600		5
	Acquired Technologies	1,700		8
	Non-compete agreements	219		2
		$	30,219

Business Acquisition, Pro Forma Information



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue	$	382,859	$	293,072	$	1,062,798	$	838,109
Net income	$	34,350	$	9,091	$	63,513	$	24,088
Net income per common share:
Basic	$	0.72	$	0.20	$	1.34	$	0.52
Diluted	$	0.70	$	0.19	$	1.30	$	0.50

Net Income Per Common Share (Tables)

9 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Computation of basic and diluted net income per common share

The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2015 and 2014, respectively:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Net income	$	33,647	$	8,499	$	61,726	$	23,322

Net income per common share - basic	$	0.71	$	0.18	$	1.30	$	0.50
Net income per common share - diluted	$	0.69	$	0.18	$	1.27	$	0.49

Weighted average common shares outstanding - basic	47,674		46,546		47,466		46,460
Plus dilutive effect of potential common shares	1,304		1,576		1,271		1,499
Weighted average common shares outstanding - diluted	48,978		48,122		48,737		47,959

Segment Information (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Revenue
Nurse and allied healthcare staffing	$	266,279	$	174,292	$	735,341	$	503,636
Locum tenens staffing	101,755		78,816		285,835		219,996
Physician permanent placement services	14,825		11,476		39,337		32,746
	$	382,859	$	264,584	$	1,060,513	$	756,378
Segment Operating Income
Nurse and allied healthcare staffing	$	40,873	$	21,279	$	108,169	$	63,283
Locum tenens staffing	13,321		8,139		34,142		22,830
Physician permanent placement services	4,555		2,756		11,103		7,074
	58,749		32,174		153,414		93,187
Unallocated corporate overhead	13,817		10,396		38,681		26,958
Depreciation and amortization	5,304		4,086		15,631		11,916
Share-based compensation	2,021		1,791		6,551		5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013		1,433		5,797		7,908
Income before income taxes	$	35,594	$	14,468	$	86,754	$	41,044

Fair Value Measurement (Tables)

9 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities measured at fair value on recurring basis

The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:



	Fair Value Measurements as of September 30, 2015
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds	$	5,626	$	5,626	$	—	$	—
Interest rate swap liability	542		—		542		—
Acquisition contingent consideration earn-out liabilities	3,800		—		—		3,800
Total financial assets and liabilities measured at fair value	$	9,968	$	5,626	$	542	$	3,800



	Fair Value Measurements as of December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
U.S. Treasury securities	$	5,291	$	5,291	$	—	$	—
Money market funds	335		335		—		—
Acquisition contingent consideration earn-out liability	1,400		—		—		1,400
Total financial assets and liabilities measured at fair value	$	7,026	$	5,626	$	—	$	1,400

Reconciliations of changes in the fair value of contingent consideration liabilities

The following table sets forth reconciliations of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:



	Three months ended September 30,
	2015			2014
Balance as of July 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—



	Nine months ended September 30,
	2015			2014
Balance as of January 1	$	1,400		$	—
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300		)	—
Additional contingent consideration earn-out liability from TFS acquisition	2,700			—
Balance as of September 30	$	3,800		$	—

Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2015

Balance Sheet Related Disclosures [Abstract]

Schedule of Supplemental Balance Sheet Disclosures

The consolidated balance sheets detail is as follows as of September 30, 2015 and December 31, 2014:



	September 30, 2015			December 31, 2014
Other current assets:
Restricted cash	$	13,143		$	9,054
Income taxes receivable	4,195			3,503
Other	7,739			4,643
Other current assets	$	25,077		$	17,200

Fixed assets:
Furniture and equipment	$	21,158		$	17,761
Software	93,485			78,593
Leasehold improvements	5,224			5,340
	119,867			101,694
Accumulated depreciation and amortization	(74,460		)	(68,814		)
Fixed assets, net	$	45,407		$	32,880

Accounts payable and accrued expenses:
Trade accounts payable	$	48,109		$	30,039
Subcontractor payable	53,575			33,474
Professional liability reserve	7,403			7,380
Overdraft	2,548			6,338
Other	1,517			1,762
Accounts payable and accrued expenses	$	113,152		$	78,993

Accrued compensation and benefits:
Accrued payroll	$	32,569		$	21,857
Accrued bonuses	20,218			15,196
Accrued travel expense	2,868			2,413
Accrued health insurance reserve	2,517			1,871
Accrued workers compensation reserve	7,539			5,830
Deferred compensation	21,968			20,729
Other	813			99
Accrued compensation and benefits	$	88,492		$	67,995

Business Combinations (Details)						3 Months Ended		9 Months Ended
Business Combinations (Details)	Sep. 15, 2017 USD ($)	Sep. 15, 2016 USD ($)	Sep. 15, 2015 USD ($)	Jan. 07, 2015 USD ($) subsidiary	Dec. 22, 2014 USD ($)	Sep. 30, 2015 USD ($) $ / shares	Sep. 30, 2014 USD ($) $ / shares	Sep. 30, 2015 USD ($) $ / shares	Sep. 30, 2014 USD ($) $ / shares	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2014 USD ($)
Business Combination, Description
Additional cash paid for working capital adjustment settlement								$ 165,000	$ 0
Allocation of Purchase Price
Goodwill						$ 201,444,000		201,444,000				$ 154,387,000
The First String Healthcare Acquisition [Member]
Business Combination, Description
Total purchase price of the acquisition			$ 7,653,000
Cash consideration			4,453,000
Fair value of contingent earn-out			2,700,000
Contingent earn-out based on future operating performance			4,000,000
Allocation of Purchase Price
Fair value of assets acquired			920,000
Liabilities assumed			867,000
Identified intangible assets			3,373,000
Goodwill			$ 4,228,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets			7 years
The First String Healthcare Acquisition [Member] \| Scenario, Forecast [Member]
Business Combination, Description
Cash consideration		$ 500,000
Contingent earn-out future payments	$ 1,000,000
The First String Healthcare Acquisition [Member] \| Scenario, Forecast [Member] \| Earn-Out Payment, Payable in 2016 Based on TFS Results in 2015 [Member]
Business Combination, Description
Contingent earn-out based on future operating performance											$ 1,000,000
The First String Healthcare Acquisition [Member] \| Scenario, Forecast [Member] \| Earn-Out Payment, Payable in 2017 Based on TFS Results in 2016 [Member]
Business Combination, Description
Contingent earn-out based on future operating performance										$ 3,000,000
Onward Healthcare Acquisition [Member]
Business Combination, Description
Cash consideration				$ 76,643,000
Number of subsidiaries acquired with parent \| subsidiary				2
Allocation of Purchase Price
Fair value of assets acquired				$ 25,420,000
Liabilities assumed				21,659,000
Identified intangible assets				30,219,000
Goodwill				42,663,000
Accounts receivable acquired				20,269,000
Accounts payable assumed				$ 10,534,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets				11 years
Business Acquisition, Pro Forma Information [Abstract]
Actual acquiree revenue since date of acquisition						39,145,000		106,492,000
Actual acquiree income before income taxes since date of acquisition						4,774,000		11,416,000
Pro forma revenue						382,859,000	$ 293,072,000	1,062,798,000	838,109,000
Pro forma net income						$ 34,350,000	$ 9,091,000	$ 63,513,000	$ 24,088,000
Net income per common share, basic (in dollars per share) \| $ / shares						$ 0.72	$ 0.20	$ 1.34	$ 0.52
Net income per common share, diluted (in dollars per share) \| $ / shares						$ 0.70	$ 0.19	$ 1.30	$ 0.50
Onward Healthcare Acquisition [Member] \| Nurse and allied healthcare staffing [Member]
Allocation of Purchase Price
Goodwill				$ 37,422,000
Onward Healthcare Acquisition [Member] \| Locum tenens staffing [Member]
Allocation of Purchase Price
Goodwill				5,241,000
Onward Healthcare Acquisition [Member] \| Tradenames and trademarks [Member]
Allocation of Purchase Price
Identified intangible assets				8,100,000
Onward Healthcare Acquisition [Member] \| Customer relationships [Member]
Allocation of Purchase Price
Identified intangible assets				17,600,000
Onward Healthcare Acquisition [Member] \| Staffing database [Member]
Allocation of Purchase Price
Identified intangible assets				$ 2,600,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				5 years
Onward Healthcare Acquisition [Member] \| Technologies [Member]
Allocation of Purchase Price
Identified intangible assets				$ 1,700,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				8 years
Onward Healthcare Acquisition [Member] \| Noncompete agreements [Member]
Allocation of Purchase Price
Identified intangible assets				$ 219,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				2 years
Onward Healthcare Acquisition [Member] \| Minimum [Member] \| Tradenames and trademarks [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				3 years
Onward Healthcare Acquisition [Member] \| Minimum [Member] \| Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				10 years
Onward Healthcare Acquisition [Member] \| Maximum [Member] \| Tradenames and trademarks [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				15 years
Onward Healthcare Acquisition [Member] \| Maximum [Member] \| Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Useful life				15 years
Avantas Acquisition [Member]
Business Combination, Description
Total purchase price of the acquisition					$ 17,520,000
Cash consideration					14,470,000
Fair value of contingent earn-out						$ 1,100,000		$ 1,100,000
Contingent earn-out based on future operating performance					8,500,000
Cash holdback for potential claims					1,650,000
Contingent earn-out					1,400,000	1,100,000		1,100,000
Additional cash paid for working capital adjustment settlement					165,000
Allocation of Purchase Price
Fair value of assets acquired					1,631,000
Liabilities assumed					3,821,000
Identified intangible assets					9,960,000
Goodwill					$ 9,916,000
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life of intangible assets					14 years
Contingent Consideration [Member] \| Fair Value, Inputs, Level 3 [Member]
Business Combination, Description
Decrease in operating expenses						(300,000)	$ 0	$ (300,000)	$ 0
Contingent Consideration [Member] \| Fair Value, Inputs, Level 3 [Member] \| Avantas Acquisition [Member]
Business Combination, Description
Decrease in operating expenses						$ (300,000)

Revenue Recognition (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Revenue Recognition [Abstract]
Payables to subcontractor	$ 53,575	$ 33,474

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Common stock excluded from calculation of EPS		286	12	344
Computation of basic and diluted net income per common share
Net income	$ 33,647	$ 8,499	$ 61,726	$ 23,322
Net income per common share - basic (in dollars per share)	$ 0.71	$ 0.18	$ 1.30	$ 0.50
Net income per common share - diluted (in dollars per share)	$ 0.69	$ 0.18	$ 1.27	$ 0.49
Weighted average common shares outstanding - basic	47,674	46,546	47,466	46,460
Plus dilutive effect of potential common shares	1,304	1,576	1,271	1,499
Weighted average common shares outstanding - diluted	48,978	48,122	48,737	47,959

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
Segment Information (Details) $ in Thousands	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) segment	Sep. 30, 2014 USD ($)
Segment Reporting [Abstract]
Reportable business segments \| segment			3
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	$ 382,859	$ 264,584	$ 1,060,513	$ 756,378
Operating Income	37,607	15,901	92,551	48,952
Depreciation and amortization	5,304	4,086	15,631	11,916
Share-based compensation	2,021	1,791	6,551	5,361
Interest expense, net (including loss on debt extinguishment of $3,113 for the nine months ended September 30, 2014), and other	2,013	1,433	5,797	7,908
Income before income taxes	35,594	14,468	86,754	41,044
Loss on debt extinguishment		0	0	3,113
Operating segments [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	382,859	264,584	1,060,513	756,378
Operating Income	58,749	32,174	153,414	93,187
Operating segments [Member] \| Nurse and allied healthcare staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	266,279	174,292	735,341	503,636
Operating Income	40,873	21,279	108,169	63,283
Operating segments [Member] \| Locum tenens staffing [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	101,755	78,816	285,835	219,996
Operating Income	13,321	8,139	34,142	22,830
Operating segments [Member] \| Physician permanent placement services [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Revenue	14,825	11,476	39,337	32,746
Operating Income	4,555	2,756	11,103	7,074
Corporate, non-segment [Member]
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results
Unallocated corporate overhead	$ 13,817	$ 10,396	$ 38,681	$ 26,958

Derivative Instruments (Details) - Interest Rate Swap [Member] - Designated as Hedging Instrument [Member] - USD ($)	Sep. 30, 2015	Apr. 30, 2015
Derivative [Line Items]
Interest rate swap, face amount		$ 100,000,000
Fixed rate on interest rate swap, percent		0.983%
Other Assets [Member]
Derivative [Line Items]
Fair value of interest rate swap	$ (542,000)

Fair Value Measurement - Textual (Details)	3 Months Ended		9 Months Ended
Fair Value Measurement - Textual (Details)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) tier	Sep. 30, 2014 USD ($)	Sep. 15, 2015 USD ($)	Dec. 22, 2014 USD ($)
Avantas Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance						$ 8,500,000
Contingent earn-out	$ 1,100,000		$ 1,100,000
The First String Healthcare Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance					$ 4,000,000
Contingent earn-out					$ 2,700,000
Contingent Consideration [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Decrease in operating expenses	(300,000)	$ 0	$ (300,000)	$ 0
Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers \| tier			5
Decrease in operating expenses	(300,000)
Financial Performance Of Calendar Year 2015 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers \| tier			3
Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of earn-out tiers \| tier			6
Earn-out Tier 1 [Member] \| Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		$ 0
Earn-out Tier 1 [Member] \| Financial Performance Of Calendar Year 2015 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		0
Earn-out Tier 1 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	0		0
Earn-out Tier 2 [Member] \| Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,500,000		1,500,000
Earn-out Tier 2 [Member] \| Financial Performance Of Calendar Year 2015 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	500,000		500,000
Earn-out Tier 2 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,000,000		1,000,000
Earn-out Tier 3 [Member] \| Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	3,500,000		3,500,000
Earn-out Tier 3 [Member] \| Financial Performance Of Calendar Year 2015 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,000,000		1,000,000
Earn-out Tier 3 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	1,500,000		1,500,000
Earn-out Tier 4 [Member] \| Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	5,500,000		5,500,000
Earn-out Tier 4 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	2,000,000		2,000,000
Earn-out Tier 5 [Member] \| Contingent Consideration [Member] \| Avantas Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	8,500,000		8,500,000
Earn-out Tier 5 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	2,500,000		2,500,000
Earn-out Tier 6 [Member] \| Financial Performance Of Calendar Year 2016 [Member] \| Contingent Consideration [Member] \| The First String Healthcare Acquisition [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent earn-out based on future operating performance	$ 3,000,000		$ 3,000,000

Fair Value Measurement Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) - Fair Value, Inputs, Level 3 [Member] - Contingent Consideration [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 1,400	$ 0	$ 1,400	$ 0
Change in fair value of contingent consideration earn-out liability from Avantas acquisition	(300)	0	(300)	0
Additional contingent consideration earn-out liability from TFS acquisition	2,700	0	2,700	0
Ending balance	$ 3,800	$ 0	$ 3,800	$ 0

Income Taxes (Details) - USD ($) $ in Thousands	1 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Jul. 31, 2015	Dec. 31, 2016	Sep. 30, 2015
Federal Tax Authority [Member]
Income Tax Examination [Line Items]
Income tax benefits to be recorded in connection with settlement			$ 12,200
Federal Tax Authority [Member] \| Internal Revenue Service (IRS) [Member]
Income Tax Examination [Line Items]
Tax settlement amount	$ 7,200
Scenario, Forecast [Member] \| State Jurisdiction [Member]
Income Tax Examination [Line Items]
Income tax benefits to be recorded in connection with settlement		$ 1,500

Commitments and Contingencies - Leases (Details) $ in Thousands	Jan. 26, 2015 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Operating lease agreement term	10 years
Total minimum lease payments	$ 23,956

Balance Sheet Details (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Other current assets:
Restricted cash	$ 13,143	$ 9,054
Income taxes receivable	4,195	3,503
Other	7,739	4,643
Other current assets	25,077	17,200
Fixed assets:
Furniture and equipment	21,158	17,761
Software	93,485	78,593
Leasehold improvements	5,224	5,340
Fixed assets, gross	119,867	101,694
Accumulated depreciation and amortization	(74,460)	(68,814)
Fixed assets, net	45,407	32,880
Accounts payable and accrued expenses:
Trade accounts payable	48,109	30,039
Subcontractor payable	53,575	33,474
Professional liability reserve	7,403	7,380
Overdraft	2,548	6,338
Other	1,517	1,762
Accounts payable and accrued expenses	113,152	78,993
Accrued compensation and benefits:
Accrued payroll	32,569	21,857
Accrued bonuses	20,218	15,196
Accrued travel expense	2,868	2,413
Accrued health insurance reserve	2,517	1,871
Accrued workers compensation reserve	7,539	5,830
Deferred compensation	21,968	20,729
Other	813	99
Accrued compensation and benefits	$ 88,492	$ 67,995

Subsequent Events (Details) $ in Thousands	Oct. 05, 2015 USD ($)
Millican Solutions, Inc. [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Cash consideration	$ 4,075

Fair Value Measurement - Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	$ 9,968	$ 7,026
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	5,626
Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	542	0
Significant Unobservable Inputs (Level 3) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	1,400
Securities (Assets) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		5,291
Securities (Assets) [Member] \| Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	335
Securities (Assets) [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		5,291
Securities (Assets) [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	5,626	335
Securities (Assets) [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		0
Securities (Assets) [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Securities (Assets) [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| US Treasury securities [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value		0
Securities (Assets) [Member] \| Significant Unobservable Inputs (Level 3) [Member] \| Money Market Funds [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	1,400
Contingent Consideration [Member] \| Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	0	0
Contingent Consideration [Member] \| Significant Unobservable Inputs (Level 3) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	3,800	$ 1,400
Interest Rate Swap [Member] \| Derivative Financial Instruments, Assets [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	542
Interest Rate Swap [Member] \| Derivative Financial Instruments, Assets [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Schedule of financial assets and liabilities measured at fair value on recurring basis
Financial assets and liabilities measured at fair value	$ 542